A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis

Cynthia Aranow, John Cush, Marcy B. Bolster, Christopher C. Striebich, Maria Dall'era, Meggan MacKay, Ewa Olech, Tracy Frech, Jane Box, Richard Keating, Mary Chester Wasko, William St Clair, Alan Kivitz, Weiquang Huang, Peta Gay Ricketts, Beverly Welch, Sherrie Callahan, Meagan Spychala, Karen Boyle, Kate YorkLynette Keyes-Elstein, Ellen Goldmuntz, Betty Diamond, Anne Davidson

Internal Medicine
Rheumatic Diseases

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Sort by
Weight
Alphabetically

A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis

Fingerprint

Medicine & Life Sciences